Published in Ann Surg on December 01, 2002
Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg (2003) 2.03
Liver transplantation: past, present and future. Nat Rev Gastroenterol Hepatol (2013) 1.11
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut (2006) 0.89
Recurrence of hepatitis C after liver transplantation. Ann Gastroenterol (2013) 0.88
Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl (2009) 0.87
Liver physiology and liver diseases in the elderly. World J Gastroenterol (2013) 0.84
Liver retransplantation in adults: a single-centre, 25-year experience. HPB (Oxford) (2010) 0.80
Costs of second allogeneic hematopoietic cell transplantation. Transplantation (2013) 0.80
Effects of graft quality on non-urgent liver retransplantation survival: should we avoid high-risk donors? World J Surg (2012) 0.77
Evaluating the Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus in Liver Transplant Patients Based on Data from Routine Clinical Practice. Drugs Real World Outcomes (2016) 0.75
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence. World J Gastroenterol (2016) 0.75
Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients. Transplant Direct (2016) 0.75
Liver retransplantation in adults: the largest multicenter Italian study. PLoS One (2012) 0.75
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. JAMA (1993) 2.56
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Long-term survival after retransplantation of the liver. Ann Surg (1997) 1.91
Retransplantation of the liver. Semin Liver Dis (1985) 1.73
Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation (1994) 1.18
Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc (1990) 1.14
Retransplantation of the liver--a seven-year experience. Transplantation (1993) 1.06
A simple model to estimate survival after retransplantation of the liver. Transplantation (1999) 1.02
Hepatic retransplantation in New England--a regional experience and survival model. Transplantation (1993) 1.01
Is retransplantation cost effective? Transplant Proc (1993) 1.00
Hepatic retransplantation: the Hannover experience of two decades. Transplant Proc (1993) 0.99
Policies in Europe on "marginal quality" donor livers. Lancet (1994) 0.98
Liver retransplantation in adults: overall results and determinant factors affecting the outcome. Transplant Proc (1991) 0.98
Posttransplant problems requiring regrafting: an analysis of 72 patients with 96 liver retransplants. Transplant Proc (1995) 0.98
Liver retransplantation--indications, frequency, results. Transplant Proc (1992) 0.98
Comparison of perioperative morbidity following primary liver transplantation and liver retransplantation. Transplant Proc (1993) 0.96
A model to predict survival following liver retransplantation. Hepatology (1999) 0.95
Clinical characteristics affecting the outcome of liver retransplantation. Transplantation (1997) 0.93
Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl (2000) 0.92
Incidence and survival rate of hepatic retransplantation in a series of 300 orthotopic liver transplants. Transplant Proc (2000) 0.79
Improvement of technique for adult orthotopic liver retransplantation. J Am Coll Surg (1995) 0.79
Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology (1999) 0.78
Hepatic retransplantation: University of Nebraska Medical Center experience. Clin Transplant (1992) 0.78
Liver retransplantation. Transplant Proc (1999) 0.78
Repeat orthotopic liver transplantation in the 1990s: is it justified? Transpl Int (1998) 0.78
Liver retransplantation: the University of Wisconsin experience. Transplant Proc (1991) 0.78
International network of cancer genome projects. Nature (2010) 20.35
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology (2013) 5.88
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol (2013) 5.64
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology (2006) 5.46
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.96
Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology (2003) 2.71
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol (2006) 2.71
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology (2003) 2.64
Liver resection for colorectal metastases: the third hepatectomy. Ann Surg (2003) 2.57
Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg (2006) 2.49
Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol (2006) 2.49
Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol (2008) 2.44
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol (2009) 2.26
Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology (2011) 2.25
Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation (2002) 2.19
Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg (2012) 2.18
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcome. Transplantation (2012) 2.11
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl (2007) 2.08
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology (2002) 2.06
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology (2012) 2.01
Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol (2011) 1.99
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA (2008) 1.94
R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg (2008) 1.88
Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg (2011) 1.83
Functions of autophagy in normal and diseased liver. Autophagy (2013) 1.81
A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg (2002) 1.78
Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases. J Hepatol (2006) 1.72
Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol (2008) 1.70
Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol (2013) 1.68
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66
Management of critically-ill cirrhotic patients. J Hepatol (2012) 1.65
Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis. J Hepatol (2010) 1.60
Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg (2008) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transpl (2006) 1.56
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transpl (2006) 1.53
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation (2004) 1.51
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease. Clin Gastroenterol Hepatol (2010) 1.49
Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology (2008) 1.49
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology (2008) 1.47
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients. J Hepatol (2011) 1.46
HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis. Hepatology (2003) 1.44